Is it time to reconsider long-term use of four large classes of cardiovascular drugs? In a review article recently published in the Journal of the American College of Cardiology, the…
Read More
Twenty lives and $440,000 over a year. For every 1,000 patients. That’s what CYP2C19 pharmacogenetic testing could save if used to help prescribe clopidogrel (Plavix), prasugrel or ticagrelor to specific…
Read More
People regularly taking a common type of painkiller called an NSAID may be at greater risk for heart attack or stroke than previously thought. The U.S. Food and Drug Administration…
Read More
The evidence for expanded use of pharmacogenetic data to help inform heart medication prescribing just got stronger. A comprehensive review of the scientific literature on pharmacogenomics and heart medications found…
Read More
